InvestSMART

AFT Pharmaceuticals Limited (ASX:AFP)

ALERT: Price-sensitive ASX Announcement for AFP
Current share price for AFP : $3.140 0.28 (9.79%)+
Announcement
Release
21 May 2026 7:31AM
Price at Release
$2.860
Full Release
download
Summary
AFT Pharmaceuticals Limited announced its financial results for the year ending 31 March 2026. The company reported a total revenue of NZ$254,705,000, marking a 22% increase from the previous year. The net profit from continuing operations rose by 23% to NZ$14,730,000. The company declared a dividend of NZ$0.018 per quoted equity security, with no imputation. The record date for the dividend is 16 June 2025, and the payment date is 4 July 2025. The net tangible assets per quoted equity security increased to NZ$0.43 from NZ$0.37 in the prior comparable period. These results are supported by audited consolidated financial statements, ensuring compliance with NZX Main Board rules and ASX listing regulations.
Key Points
  • Revenue from continuing operations increased by 22% to NZ$254,705,000.
  • Net profit from continuing operations increased by 23% to NZ$14,730,000.
  • Declared a dividend of NZ$0.018 per quoted equity security.
  • Record date for dividend is 16 June 2025; payment date is 4 July 2025.
  • Net tangible assets per quoted equity security increased to NZ$0.43.
  • Compliant with NZX and ASX listing rules.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.